Purchases and Sales Made in Q3 2022 in Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO) during Q3 2022. The information is specifically focused on institutions that hold shares of BridgeBio Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-299K- 27.89% |
$2.37M - $3.69M
|
772K
$18.1M
|
|
|
Nov 10, 2022
Q3 2022
|
Candriam S.C.A.
|
SELL
|
- |
-306K- 76.17% |
$2.43M - $3.78M
|
95.8K
$2.24M
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-311K- 23.28% |
$2.47M - $3.84M
|
1.02M
$24M
|
|
|
Nov 14, 2022
Q3 2022
|
Aristeia Capital LLC
Greenwich, CT |
SELL
|
- |
-400K- 72.73% |
$3.18M - $4.94M
|
150K
$3.51M
|
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-3.01M- 27.51% |
$23.9M - $37.3M
|
7.94M
$186M
|